HERON THERAPEUTICS, INC. /DE/ — Director's Dealing 2016

Jun 23, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HERON THERAPEUTICS, INC. /DE/ (HRTX)
CIK: 0000818033
Period of Report: 2016-06-22

Reporting Person: Christian Waage (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-22	Stock Option (Right to Buy)	$17.89	A	25000	Acquired	2026-06-22	Common Stock (25000)	Direct
2016-06-22	Stock Option (Right to Buy)	$17.89	A	1500	Acquired	2026-06-22	Common Stock (1500)	Direct

Footnotes

F1: The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant.

F2: The stock option vests and becomes exercisable in six equal monthly installments beginning one month after the date of grant.